Krsnaa Diagnostics [KRSNAA] vs Indoco Remedies [INDOCO] Detailed Stock Comparison

Krsnaa Diagnostics Ltd.

NSE
Loading...

Indoco Remedies Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Krsnaa Diagnostics Ltd. wins in 12 metrics, Indoco Remedies Ltd. wins in 7 metrics, with 0 ties. Krsnaa Diagnostics Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Krsnaa Diagnostics Ltd. Indoco Remedies Ltd. Better
P/E Ratio (TTM) 24.69 101.34 Krsnaa Diagnostics Ltd.
Price-to-Book Ratio 2.13 1.73 Indoco Remedies Ltd.
Debt-to-Equity Ratio 30.96 102.50 Krsnaa Diagnostics Ltd.
PEG Ratio -1.15 26.01 Indoco Remedies Ltd.
EV/EBITDA 10.20 30.05 Krsnaa Diagnostics Ltd.
Profit Margin (TTM) 10.49% -6.47% Krsnaa Diagnostics Ltd.
Operating Margin (TTM) 13.13% -0.11% Krsnaa Diagnostics Ltd.
EBITDA Margin (TTM) 13.13% N/A N/A
Return on Equity 8.79% -7.24% Krsnaa Diagnostics Ltd.
Return on Assets (TTM) 6.06% -3.03% Krsnaa Diagnostics Ltd.
Free Cash Flow (TTM) $-393.00M $-2.61B Krsnaa Diagnostics Ltd.
Dividend Yield 0.62% 0.60% Krsnaa Diagnostics Ltd.
1-Year Return -21.15% -11.36% Indoco Remedies Ltd.
Price-to-Sales Ratio (TTM) 2.56 1.12 Indoco Remedies Ltd.
Enterprise Value $21.08B $29.59B Indoco Remedies Ltd.
EV/Revenue Ratio 2.75 1.68 Indoco Remedies Ltd.
Gross Profit Margin (TTM) 70.12% 72.28% Indoco Remedies Ltd.
Revenue per Share (TTM) $237 $182 Krsnaa Diagnostics Ltd.
Earnings per Share (Diluted) $24.48 $-12.17 Krsnaa Diagnostics Ltd.
Beta (Stock Volatility) -0.03 0.44 Krsnaa Diagnostics Ltd.

Krsnaa Diagnostics Ltd. vs Indoco Remedies Ltd. Stock Performance Analysis

Loading Price Chart...

KRSNAA
INDOCO

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Krsnaa Diagnostics Ltd.0.83%0.61%-7.81%-10.16%-28.11%-27.24%
Indoco Remedies Ltd.-3.71%20.07%6.52%26.68%-3.16%4.40%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Krsnaa Diagnostics Ltd.-21.15%-7.70%-42.36%-42.36%-42.36%-42.36%
Indoco Remedies Ltd.-11.36%-24.73%-38.91%-11.17%326.83%592.46%

Performance & Financial Health Analysis: Krsnaa Diagnostics Ltd. vs Indoco Remedies Ltd.

MetricKRSNAAINDOCO
Market Information
Market Cap i₹19.83B₹18.94B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i48,33841,465
90 Day Avg. Volume i67,12049,420
Last Close₹538.75₹239.57
52 Week Range₹515.00 - ₹894.40₹162.19 - ₹349.80
% from 52W High-39.76%-31.51%
All-Time High₹1,099.70 (Aug 16, 2021)₹530.25 (Aug 09, 2021)
% from All-Time High-51.01%-54.82%
Growth Metrics
Quarterly Revenue Growth0.04%0.09%
Quarterly Earnings Growth-0.22%0.08%
Financial Health
Profit Margin (TTM) i0.10%-0.06%
Operating Margin (TTM) i0.13%0.00%
Return on Equity (TTM) i0.09%-0.07%
Debt to Equity (MRQ) i30.96102.50
Cash & Liquidity
Book Value per Share (MRQ)₹284.46₹123.55
Cash per Share (MRQ)₹40.22₹2.08
Operating Cash Flow (TTM) i₹2.45M₹-532,207,000
Levered Free Cash Flow (TTM) i₹776.08M₹-737,369,000
Dividends
Last 12-Month Dividend Yield i0.62%0.60%
Last 12-Month Dividend i₹5.25₹1.70

Valuation & Enterprise Metrics Analysis: Krsnaa Diagnostics Ltd. vs Indoco Remedies Ltd.

MetricKRSNAA (Apr 24, 2026)INDOCO (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i24.69101.34
Forward P/E i14.7934.83
PEG Ratio i-1.1526.01
Price to Sales (TTM) i2.561.12
Price to Book (MRQ) i2.131.73
Market Capitalization
Market Capitalization i₹19.83B₹18.94B
Enterprise Value i₹21.08B₹29.59B
Enterprise Value Metrics
Enterprise to Revenue i2.751.68
Enterprise to EBITDA i10.2030.05
Risk & Other Metrics
Beta i-0.030.44
Book Value per Share (MRQ) i₹284.46₹123.55

Financial Statements Comparison: Krsnaa Diagnostics Ltd. vs Indoco Remedies Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricKRSNAA (2025)INDOCO (2025)
Revenue/Sales i7.17B16.41B
Cost of Goods Sold i2.30B5.14B
COGS % of Revenue i32.1%31.3%
Gross Profit i4.87B11.27B
Gross Margin i67.9%68.7%
Research & Development iN/A760.12M
Operating Income (EBIT) i1.02B-267.15M
Operating Margin i14.2%-1.6%
EBITDA i2.08B1.00B
EBITDA Margin i29.0%6.1%
Pre-Tax Income i1.03B-743.71M
Pre-Tax Income % of Revenue i14.3%-4.5%
Income Tax i250.79M35.81M
Income Tax % of Revenue i3.5%0.2%
Net Income (Profit) i776.08M-779.51M
Profit Margin i10.8%-4.7%

Balance Sheet & Liquidity Metrics

MetricKRSNAA (2025)INDOCO (2025)
Cash & Equivalents i38.46M120.96M
Total Current Assets i4.14B10.01B
Total Current Assets % of Revenue i57.8%61.0%
Total Current Liabilities i3.05B8.08B
Total Current Liabilities % of Revenue i42.6%49.2%
Long-Term Debt i471.56M5.43B
Long-Term Debt % of Revenue i6.6%33.1%
Total Shareholders Equity i8.83B10.18B
Retained Earnings i2.00B6.72B
Retained Earnings % of Revenue i28.0%41.0%
Property, Plant & Equipment i256.28M3.54B

Cash Flow Statement Comparison

MetricKRSNAA (2025)INDOCO (2025)
Operating Cash Flow i2.45M-532.21M
Operating Cash Flow % of Revenue i0.0%-3.2%
Capital Expenditures i-1.12B37.96M
Free Cash Flow i-393.00M-2.61B
FCF Margin i-5.5%-15.9%
Debt Repayment iN/A-417.32M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricKRSNAAINDOCO
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i32.44M92.17M
Float Shares i17.39M36.39M
% Held by Insiders i44.56%60.90%
% Held by Institutions i14.97%17.82%
% Held by Public i40.47%21.28%

Dividend Analysis & Yield Comparison: Krsnaa Diagnostics Ltd. vs Indoco Remedies Ltd.

MetricKRSNAAINDOCO
Last 12-Month Dividend i₹5.25₹1.70
Last 12-Month Dividend Yield i0.62%0.60%
3-Year Avg Annual Dividend i₹3.50₹1.82
3-Year Avg Dividend Yield i0.39%0.39%
3-Year Total Dividends i₹10.50₹5.45
Ex-Dividend DateSep 12, 2025Sep 04, 2025